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Introduction
Adult neurogenesis occurs in the dentate gyrus (DG) of the 
hippocampus1,2 and in the subventricular zone (SVZ) of the 
lateral ventricle.3 Hippocampal neurogenesis plays a role in 
the maintenance of normal hippocampal function, including 
learning and memory.4,5 Hippocampal stem cells (HSCs) lie 
in the subgranular zone (SGZ), along the border between the 
hilus and the granule cell layer (GCL).6 Many of the HSCs die 
shortly after their birth,7 whereas the surviving cells migrate 
into the dentate GCL, differentiate into granule cells8 and 
project their axons to the CA3 region resulting in their mor-
phological and functional integration into the existing hip-
pocampal circuitry.9 The formation of new granule cells in 
the DG can be affected by a large number of physiological 
and pathological stimuli, such as aging and neurodegenerative 
diseases.10-13
Neuroinflammation is thought to be involved in the patho-
physiology of several neurodegenerative diseases, including 
Alzheimer disease.14 Inflammation can affect the microenviron-
ment of the neurogenic niche15 and influence proliferation of 
progenitor cells, survival and migration of new neuroblasts, dif-
ferentiation of new neuroblasts to specific neuronal phenotypes 
and development of functional synaptic connectivity.16,17
Growing evidence indicates that neuroinflammation can alter adult neurogenesis by mechanisms as yet unclear. We 
have previously demonstrated that the neuroinflammatory response and neuronal damage after lipopolysaccharide 
(LpS) injection is reduced in cyclooxygenase-1 deficient (CoX-1-/-) mice. In this study, we investigated the role of CoX-
1 on hippocampal neurogenesis during LpS-induced neuroinflammation, using CoX-1-/- and wild-type (Wt) mice. 
We found that LpS-induced neuroinflammation resulted in the decrease of proliferation, survival and differentiation 
of hippocampal progenitor cells in Wt but not in CoX-1-/- mice. thus, we demonstrate for the first time that CoX-1 is 
involved in the inhibition of BrdU progenitor cells in proliferation and hippocampal neurogenesis after LpS. these results 
suggest that CoX-1 may represent a viable therapeutic target to reduce neuroinflammation and promote neurogenesis 
in neurodegenerative diseases with a strong inflammatory component.
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Neuroinflammation is mediated by microglial activation and 
subsequent release of pro-inflammatory mediators such as prosta-
glandins, cytokines, chemokines and reactive oxygen or nitrogen 
species.18 Prostaglandin H synthases or cyclooxygenases (COX)-1 
or -2 catalyze the conversion of arachidonic acid to prostaglan-
dins.18 Because of its localization in microglia, and thus, being 
able to immediately synthesize prostaglandins in response to 
microglial activation, COX-1 recently emerged as a major player 
in the acute inflammatory response.19-21 A recent study also sug-
gested a role for COX-1 expressed in brain perivascular cells in 
mediating the immune-to-brain signaling in response to a sys-
temic lipopolysaccharide (LPS) challenge.22
In this study, we used mice with a null mutation of the COX-1 
gene to investigate the role of COX-1 on hippocampal neuro-
genesis during acute neuroinflammation induced by intracere-
broventricular injection of LPS.18 LPS binds to a CD14 receptor 
and together with the extracellular adaptor protein MD-2 binds 
to the toll-like receptor 4 (TLR4) expressed by microglia and 
astrocytes,23 causing a massive glial activation accompanied by a 
robust and transient transcriptional activation of genes encoding 
for pro-inflammatory mediators.18
We have previously shown that the genetic deletion or phar-
macological inhibition of COX-1 significantly attenuated glial 
activation, release of pro-inflammatory markers, as well as 
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cells proliferation in the DG, BrdU-labeled cells were counted 24 
h after LPS injection. The distribution of the BrdU-labeled pro-
liferative cells was found mainly in clusters at the border between 
the granule cell layer and the hilus, regardless of treatment or gen-
otype (Fig. 1A). Within the area encompassing the granule cell 
layer and subgranular zone (Fig. 1A), LPS treatment decreased by 
35% the mean density of BrdU-positive cells in WT mice (0.36 
± 0.16 vs. 0.55 ± 0.027 in vehicle-treated WT mice, p < 0.01, Fig. 
1B). In contrast, the number of BrdU-labeled proliferative cells 
was not significantly different in LPS-injected COX-1-/- com-
pared with vehicle-injected COX-1-/- mice (0.47 ± 0.05 vs. 0.53 
± 0.04) (Fig. 1B).
LPS injection reduces hippocampal neurogenesis in WT but 
not in COX-1-/- mice. To determine the fate of new hippocampal 
cells, we examined the phenotype of newly BrdU-positive cells 
generated 4 weeks after LPS injection by concomitant immu-
nolabeling of BrdU with neuronal (NeuN) and glial (S100β) 
markers (Fig. 2A). S100β, a marker for astrocytes and oligo-
dendrocytes, labels cell bodies with a better definition than 
GFAP. The percentage of BrdU-positive cells that co-localized 
with NeuN immunolabeling was significantly reduced by 35% 
in LPS-injected compared with vehicle-injected WT mice 
(p < 0.001). In contrast, the number of neurons did not differ 
significantly in LPS-injected COX-1-/- mice as compared with 
vehicle-injected COX-1-/- mice (97.3% ± 0.6% vs. 100% ± 0%; 
Fig. 2B). Furthermore, LPS-injected WT mice showed a 35% 
increase (p < 0.001) in the number of BrdU-positive cells that 
differentiated into glial cells compared with vehicle-injected mice 
(p < 0.001; Fig. 2C). Only a small percentage of BrdU-positive 
cells differentiated into glia in LPS-injected COX-1-/- mice com-
pared with their vehicle-injected controls (2.7% ± 0.7% vs. 0%, 
p < 0.01; Fig. 2C).
COX-1 is involved in the LPS-induced survival effect of 
new hippocampal cells. To test whether COX-1 is involved in 
the post-mitotic BrdU-cell survival, we analyzed the density 
of BrdU-cells in the granule cell layer and subgranular zone of 
DG 4 weeks after LPS injection in COX-1-/- and WT mice. LPS 
significantly increased the density of BrdU-survival cells com-
pared with vehicle-injection in WT mice (0.29 ± 0.01 vs. 0.22 ± 
0.006, 24%, p < 0.001), but did not affect survival of new cells in 
COX-1-/- mice compared with their respective vehicle-injected 
controls (0.24 ± 0.005 vs. 0.22 ± 0.003) (Fig. 3).
When we compared the survival BrdU-cells at 4 weeks with 
the BrdU-cells present at 24 h in the DG, after LPS or vehicle 
injection in WT and COX-1-/- mice, the density of surviving 
BrdU-cells was drastically decreased. In particularly, the surviving 
BrdU-cells in vehicle-injected WT and COX-1-/- mice was drasti-
cally reduced by 60% after 4 weeks (p < 0.001). LPS-injected 
COX-1-/- mice showed a minor reduction of surviving BrdU-cells 
after 4 weeks (49%), whereas the number of BrdU-cells was not 
significantly affected in LPS-injected WT mice (Fig. 4).
Discussion
In this study we examined the role of COX-1 in the proliferation, 
survival and differentiation of new hippocampal progenitor cells 
blood-brain barrier disruption and recruitment of peripheral leu-
kocytes to the inflamed brain in response to LPS.18,20,24 Since LPS 
has been shown to decrease hippocampal neurogenesis,12,25,26 in 
this study we investigated whether COX-1 gene deletion posi-
tively modulates hippocampal neurogenesis during LPS-induced 
neuroinflammation. We examined the proliferation, survival and 
differentiation of neuronal progenitor cells in the DG after LPS 
injection and demonstrated for the first time that COX-1 gene 
deletion resulted in an increased proliferation and differentiation 
of hippocampal progenitor cells in the adult mouse brain during 
neuroinflammation.
Results
LPS injection reduces proliferation of hippocampal progenitor 
cells in WT but not in COX-1-/- mice. To evaluate progenitor 
Figure 1. (A) Hippocampal BrdU proliferative cells after LpS-induced 
neuroinflammation in CoX-1-/- and Wt mice. Representative photomi-
crographs of BrdU immunohistochemistry in the DG for Wt (A and B) 
and CoX-1-/- mice (C and D) euthanized 24 h after i.c.v. injection of LpS or 
vehicle. High-magnification images of BrdU immunostaining is shown 
in (e). Scale bars = 100 μm (A–D); 50 μm (e). (B) Hippocampal BrdU-
proliferative cells after LpS-induced neuroinflammation in CoX-1-/- and 
Wt mice. Quantification of BrdU-labeled cells per μm3 of DG, in Wt and 
CoX-1-/- mice euthanized 24 h after i.c.v. injection of LpS or vehicle. Data 
are means ± SeM (n = 5, vehicle-injected; n = 6, LpS-injected), **p < 0.01.
2570 Cell Cycle Volume 10 Issue 15
Our results show that inhibition of the proliferation and dif-
ferentiation of progenitor cells after LPS injection can be caused 
by the inflammatory environment, and particularly, through an 
indirect effect on hippocampal progenitor cells. Indeed, neuronal 
progenitor cells do not express COX-1 (data not shown) either 
under physiological conditions or after LPS. Thus, the positive 
modulation of neurogenesis by COX-1 deletion could be an indi-
rect effect attributable to the attenuation of the neuroinflamma-
tory response.18 In this regard, the transcription factors STAT3 
and NFκB, which are upregulated after LPS-induced inflam-
mation,18,31 induce the transcription of many pro-inflammatory 
after LPS-induced neuroinflammation. We found 
that LPS-induced neuroinflammation altered the 
proliferation of progenitor cells, the production rate 
of new neurons, and the survival of new hippocampal 
progenitor cells in WT but not in COX-1-/- mice.
Previous data from our lab showed that COX-1 
plays a critical role in the neuroinflammatory response 
to LPS18 or β-amyloid injection.27 Specifically, COX-1 
gene deletion or treatment with the COX-1 specific 
inhibitor SC-560 resulted in decreased glial activa-
tion, reduced expression of pro-inflammatory cyto-
kines and chemokines, and limited neuronal damage 
after central injection of LPS.18 Taken together these 
data suggest that during neuroinflammation, COX-1 
plays a critical role in the propagation of the inflam-
matory response and in the modulation of the regen-
erative potency of hippocampal progenitor cells.
COX-1 is predominantly expressed by microglia 
and perivascular cells, and thus, can be activated, 
within seconds to minutes, following an acute chal-
lenge, and produce prostaglandins that contribute to 
the inflammatory response.28,29 Activation of COX-
1-expressing microglia and subsequent release of 
pro-inflammatory mediators such as IL-1β, IL-6, 
TNFα, NO and prostanoids, which have antineurogenic effects, 
could be responsible for the adverse effects of inflammation on 
neurogenesis.12,30
TLR4 is abundantly expressed by neural stem/progenitor cells 
and the absence of TLR4 results in enhanced proliferation and 
neuronal differentiation,31 suggesting that TLR4 directly modu-
lates self-renewal and the cell-fate decision of neuronal progenitor 
cells.31 Rolls et al. (2007) reported that LPS treatment decreases 
the proliferation and differentiation of cultured neural stem/
progenitor cells via a nuclear factor kappaB (NFκB) signaling 
TLR-4 dependent.31
Figure 2. (A) Hippocampal BrdU-cells differentiation 
after LpS-induced neuroinflammation in CoX-1-/- and Wt 
mice. Confocal images of DG for Wt (A and B) and CoX-1-/- 
mice (C and D) euthanized 4 weeks after i.c.v. injection of 
LpS or vehicle. Sections were triple-labeled for BrdU (red), 
NeuN (green) and S100β (blue). Scale bars = 20 μm.  
(B) Differentiation of new hippocampal cells 4 weeks after 
LpS-induced neuroinflammation in CoX-1-/- and Wt mice. 
Quantification of percentage of BrdU-cells differentiated 
into neurons in Wt and CoX-1-/- mice after 4 weeks of i.c.v. 
injection of LpS or vehicle. Data are means ± SeM (n = 4), 
***p < 0.001, LpS-injected Wt mice vs. vehicle-injected 
Wt mice; ###p < 0.001, LpS-injected CoX-1-/- mice vs. LpS-
injected Wt mice. (C) Differentiation of new hippocampal 
cells 4 weeks after LpS-induced neuroinflammation in 
CoX-1-/- and Wt mice. Quantification of percentage of 
BrdU-cells differentiated into glia in Wt and CoX-1-/- mice 
4 weeks after i.c.v. injection of LpS or vehicle. Data are 
means ± SeM (n = 4), ***p < 0.001, LpS-injected Wt mice 
vs. vehicle-injected Wt mice; **p < 0.01, LpS-injected 
CoX-1-/- mice vs. vehicle-injected CoX-1-/- mice; ###p < 
0.001, LpS-injected Wt mice vs. LpS-injected CoX-1-/- 
mice.
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survival effect in the new hippocampal progenitor cells to replace 
damaged neurons in the inflamed brain, although many new 
progenitor cells will differentiate into glial cells.
When we compare the survival of BrdU positive cells 24 h 
and 4 weeks after LPS injection, COX-1-/- mice showed a strong 
decrease in surviving cells that was not observed in WT mice 
(49% vs. 17%, respectively). This difference could be linked to 
the reduction of inflammatory response and neuronal damage 
in COX-1-/- mice after LPS, which would make unnecessary for 
new hippocampal cells to survive as in vehicle-injected WT and 
COX-1-/- mice.
New hippocampal neurons that survive chronic inflammatory 
stress differentiate and integrate as granule neurons, although 
with a heightened degree of synaptic plasticity.41,42 Recent work 
showed that new neurons exposed to the chronic pathological 
environment are severely controlled,41,43,44 and can exhibit subtle 
changes in development of dendritic arborizations and spine den-
sity,45 which are dependent on the characteristics of the patho-
logical environment.45 Apical dendrites reached the molecular 
layer during the first 2 weeks after their birth, and the dendritic 
arborizations and the development of spines occurs during the 
first 3–4 weeks.41 Since pilot studies in our lab showed that LPS-
induced neuroinflammation peaks at 24 h and then resolves in 
few days (Choi et al. 2008), one could speculate that new hippo-
campal cells develop normally and integrate into the hippocam-
pal network, without undergoing morphological or functional 
changes. However, only electrophysiological studies can confirm 
a functional integration of new hippocampal cells into the hip-
pocampal functional circuitry.
Neuroinflammation is a complex mechanism, in which dif-
ferent pathways, intracellular and extracellular, can interact and 
both directly and indirectly modulate the neurogenic niche. 
In addition to a TLR4-dependent mechanism, we suggest that 
COX-1 plays a role in the inhibition of hippocampal neurogene-
sis after LPS injection.32,34,46 COX-1-derived prostaglandins, such 
as PGE
2
, could directly affect the neurogenic niche, although it 
genes18 and play a critical role in controlling the proliferation of 
neuronal stem cells32 and neuronal differentiation.18 Supporting 
a role for these transcription factors, our group has previously 
demonstrated that, in response to LPS, COX-1-/- mice or WT 
treated with SC-560 have decreased activation and translocation 
of NFκB and STAT-3, and reduced levels of the pro-inflamma-
tory cytokines IL-1β, IL-6 and TNFα.18
The differentiation of neuronal progenitor cells toward 
neuronal or glial lineage is determined by specific signaling 
cascades regulating the activation of different transcription fac-
tors. Multiple processes directing cell fate determination can be 
modulated by different cytokines and transcription factors. IL-6, 
TNFα and IL-132,33 promote astrocytic differentiation by activat-
ing the transcription factors STAT3 and NFκB.34,35 Furthermore, 
activation of cytokine receptors on neuronal progenitor cells 
stimulates the Notch1 pathway signaling, which inhibits neu-
ronal differentiation through a hairy-enhancer-of split 1 (Hes-
1)-mediated mechanism.15,36 Notch signaling increases the 
expression of Hes-1,36 which antagonizes pro-neural basic helix-
loop-helix transcription factors and represses the commitment 
of neuronal progenitor cells to a neuronal fate.37 The cross-talk 
of all these transcription factors and their co-activators could 
modulate astrocytic fate specification in hippocampal progenitor 
cells after LPS-induced neuroinflammation. Furthermore, LPS 
injection downregulates the expression of NeuroD2, a marker of 
neuronal progenitor cells, which is thought to play a role in the 
determination and maintenance of the neuronal cells fate.38
Functional stimuli, including learning, memory and environ-
mental enrichment can increase the number of surviving BrdU-
cells by a “survival promoting effect.”39,40 In our study, we showed 
that neuroinflammation also has a survival promoting effect on 
new hippocampal progenitor cells. After 4 weeks of LPS injec-
tion, WT mice showed a 24% increase in surviving BrdU-cells 
compared with vehicle-injected WT mice. This LPS-induced 
survival promoting effect was not observed in COX-1-/- mice. 
This could be due to the reduced neuroinflammatory response 
observed in COX-1-/- mice, as neuroinflammation could trigger a 
Figure 3. Survival of new hippocampal cells 4 weeks after LpS-induced 
neuroinflammation in CoX-1-/- and Wt mice. Quantification of BrdU-
labeled cells per μm3 of DG in Wt and CoX-1-/- mice 4 weeks after i.c.v. 
injection of LpS or vehicle. Data are means ± SeM (n = 4), ***p < 0.001, 
LpS-injected Wt mice vs. vehicle-injected Wt mice; ##p < 0.01, LpS-
injected CoX-1-/- vs. LpS-injected Wt mice.
Figure 4. Comparison between survival of BrdU-labeled cells at 24 h 
and 4 weeks after LpS injection in Wt and CoX-1-/- mice. the surviving 
BrdU-cells in LpS-injected CoX-1-/- mice was severely reduced by 49% 
after 4 weeks, whereas the number of BrdU-cells was not significantly 
affected in LpS-injected Wt mice. Data are means ± SeM (n = 5, 24 h 
after LpS; n = 4, 4 weeks after LpS); **p < 0.01, LpS-injected CoX-1-/- vs. 
LpS-injected Wt mice, 4 weeks after injection.
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triple labeling for BrdU were performed on free-floating 
40 μm sagittal sections that were pretreated by denaturing DNA, 
as described previously in reference 48. The antibodies were 
mouse BrdU-antibody (1:100, DAKO, Denmark), rat anti-BrdU 
for triple labeling (1:200; Accurate Chemical and scientific, 
Westbury NY), rabbit anti-S-100β (1:200; Abcam, Cambridge, 
MA), mouse anti-NeuN (1:1,500; Chemicon, Billerica, MA). 
For immunohistochemistry the peroxidase method (ABC sys-
tem) with biotinylated donkey anti-mouse IgG antibodies and 
diaminobenzidine as chromogen was used (Vector laborato-
ries). Immunohistochemistry images were detected with a light 
microscope Olympus CKX41, using X40 and X60 objective 
(Olympus). The fluorescent antibodies 488-Alexa Flour anti-
mouse IgG (1:500), 594-Alexa Fluor anti-rat IgG (1:500) and 
405-Alexa Fluor anti-rabbit IgG (1:500) (Invitrogen, Carlsbad, 
CA) were used. Fluorescent signals were detected and processed 
using an inverted confocal microscope (model IX81, Olympus 
America Inc., Center Valley, PA) with Fluoview 1000 scanning 
head. Fluorescent images were acquired using a UPlanSApo X10 
numerical aperture (NA) 0.4 dry objective and a UPlanSApo 
X60 NA 1.42 oil immersion objective (Olympus America Inc.), 
and were processed using Imaris 5.7 (Bitplane) and assembled 
using Adobe Photoshop CS.
Cell counting and volumetric analysis. BrdU-labeled cells 
were counted in the subgranular zone, which was defined as a 
2-nucleus-wide band below the apparent border between the 
GCL and the hilus.8 We detected one every six sections and cov-
ered the entire area of dentate gyrus. To measure the DG area, 
slices were stained with hematoxylin (Vector, Burlingome, CA) 
and the area was traced using ImageJ Software. The mean den-
sity of BrdU-labeled cells in each mouse was calculated as the 
total number of labeled nuclei divided by the volume of DG (cell 
density per μm3).49 To determine the percentage of neuronal dif-
ferentiation of newborn cells, one every six sections was analyzed 
for the entire area of dentate gyrus. For each animal 50 BrdU-
positive cells were randomly selected and analyzed.49
Statistical analysis. All data are expressed as means ± SEM. 
Statistical significance was assessed with a two-way ANOVA 
followed by Bonferroni’s post hoc test using GraphPad Prism. 
Significance was taken at p < 0.05.
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remains to be fully elucidated which type(s) of prostaglandins 
and downstream receptors play a role in the modulation of neuro-
genesis.42 A recent study by Keen et al. (2009) tested the hypoth-
esis that activation of specific PGE
2
 receptors is responsible for 
suppression of hippocampal neurogenesis after LPS-induced 
neuroinflammation. They demonstrated that EP1, but not EP2, 
is expressed by progenitor cells. EP1 receptor gene deletion pro-
tected hippocampal progenitor cells from PGE
2
-mediated toxic-
ity directly and also indirectly by partially suppressing microglia 
activation and the propagation of inflammatory response. In con-
trast, EP2 was not detectably expressed by progenitor cells, and 
its ablation did not protect from direct toxic effect of PGE
2
.
Overall, our past data suggest that the inhibition of hippo-
campal neurogenesis by LPS in WT, but not COX-1-/- mice, 
could be linked to the increase in NFκB activation, expression 
of pro-inflammatory cytokines, propagation of neuroinflamma-
tion and PGE
2
 levels, all of which are attenuated by COX-1 gene 
deletion.18 We demonstrate for the first time that in LPS-induced 
neuroinflammation, COX-1 activity is detrimental to the gen-
eration of new hippocampal progenitor cells. Thus, COX-1 
inhibition may represent a viable therapeutic target to promote 
neurogenesis in neurodegenerative diseases with a strong inflam-
matory component, where neuronal loss and memory deficits are 
known to occur.
Materials and Methods
Animals and procedures. All animal procedures were performed 
under an animal study proposal approved by the National 
Institutes of Health (NIH) Animal Care and Use Committee, 
in accordance with NIH guidelines on the care and use of labo-
ratory animals. Three-month-old male WT and homozygous 
(COX-1-/-) mice on a C57BL/6-129/Ola genetic background 
were used.47 Vehicle (sterile saline, 5 μl) and LPS (Escherichia coli 
serotype 0127:B8; 5 μg in 5 μl of sterile saline) were adminis-
tered by intracerebroventricular (i.c.v.) injection into the lateral 
ventricle as previously described.18
5-bromo-2'-deoxyuridine (BrdU) was used to label the neu-
ronal progenitor cell in proliferation. Mice were given 2 BrdU 
injections with an interval of 12 h, the first 30 min prior to LPS 
injection (dissolved in 0.9% NaCl; 50 mg/Kg; 10 mg/ml, i.p.; 
Sigma Aldrich, St. Louis, MO). To detect the proliferation of 
hippocampal progenitor cells, mice were euthanized 24 h after 
LPS injection. To detect the phenotype of new born progenitor 
cells, mice were euthanized 4 weeks after LPS injection.
DNA denaturation, immunohistochemistry and immuno-
flourescence. Immunohistochemistry and immunofluorescent 
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